30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

2Q14 Revenue: LDR

$34.8MM, +31% (U.S. $26.3MM, +40%; ex-U.S. $8.4MM, +8%)

Exclusive Technology $30.4MM, +41%

  • Cervical $21.0MM, +47%
  • Lumbar $9.4MM, +29%

Traditional Fusion $4.4MM, -13%


  • Growth supported by Mobi-C, Avenue L lateral lumbar fusion, VerteBRIDGE fusion, ROI-A anterior lumbar cage, ROI-C cervical cage
  • Notes that CMS’ Hospital Inpatient Prospective Payment System Final Rule for FY15 includes new MS-DRGs for certain spine procedures, and a new MS-DRG for cervical total disc replacement, that will yield significantly higher payments (63% over current DRG, while fusion will remain essentially flat)
  • Observing evidence of Mobi-C pull-through: surgeons trained on it subsequently adopt VerteBRIDGE technology